SMI Expanded
|
1 675,07
|
-2,61
|
-0,16%
|
Analysen zu SMI Expanded-Werten
| 13.09.24 | Givaudan Neutral | UBS AG | |
| 13.09.24 | Roche Sell | Deutsche Bank AG | |
| 12.09.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 11.09.24 | DocMorris Sell | UBS AG | |
| 11.09.24 | Novartis Buy | UBS AG | |
| 11.09.24 | ABB Neutral | JP Morgan Chase & Co. | |
| 10.09.24 | Roche Neutral | UBS AG | |
| 10.09.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 10.09.24 | DocMorris Add | Baader Bank | |
| 10.09.24 | Richemont Outperform | Bernstein Research | |
| 10.09.24 | Roche Hold | Deutsche Bank AG | |
| 09.09.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 09.09.24 | Roche Neutral | UBS AG | |
| 09.09.24 | Givaudan Neutral | UBS AG | |
| 09.09.24 | UBS Overweight | JP Morgan Chase & Co. | |
| 09.09.24 | Richemont Overweight | Barclays Capital | |
| 09.09.24 | Nestlé Equal Weight | Barclays Capital | |
| 06.09.24 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 06.09.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 05.09.24 | Nestlé Neutral | UBS AG | |
| 05.09.24 | Swiss Re Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.09.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 04.09.24 | Swiss Re Equal Weight | Barclays Capital | |
| 04.09.24 | Zurich Insurance Overweight | Barclays Capital | |
| 04.09.24 | Richemont Sector Perform | RBC Capital Markets | |
| 04.09.24 | DocMorris Buy | Jefferies & Company Inc. | |
| 03.09.24 | ABB Sector Perform | RBC Capital Markets | |
| 03.09.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 03.09.24 | DocMorris Buy | Jefferies & Company Inc. | |
| 03.09.24 | Novartis Hold | Jefferies & Company Inc. | |
| 02.09.24 | Richemont Buy | UBS AG | |
| 02.09.24 | Nestlé Hold | Deutsche Bank AG | |
| 02.09.24 | DocMorris Sell | UBS AG | |
| 30.08.24 | Richemont Buy | Jefferies & Company Inc. | |
| 29.08.24 | Richemont Outperform | Bernstein Research | |
| 29.08.24 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 29.08.24 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 29.08.24 | Roche Outperform | Bernstein Research | |
| 28.08.24 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 28.08.24 | Givaudan Neutral | UBS AG |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.